A61K 31/506
Not condensed and containing further heterocyclic rings
Official title: not condensed and containing further heterocyclic rings
A61K31/506 (Not condensed and containing further heterocyclic rings) appears on 6,269 US grants and 12,246 published applications in this corpus.
Search patents in A61K- Granted patents
- 6,269
- Published applications
- 12,246
- Assignees
- 3,509
- Inventors
- 24,060
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 4 | 0 |
| 1994 | 4 | 0 |
| 1995 | 8 | 0 |
| 1996 | 8 | 0 |
| 1997 | 34 | 0 |
| 1998 | 24 | 0 |
| 1999 | 29 | 0 |
| 2000 | 28 | 0 |
| 2001 | 40 | 13 |
| 2002 | 46 | 56 |
| 2003 | 37 | 117 |
| 2004 | 36 | 142 |
| 2005 | 43 | 165 |
| 2006 | 49 | 180 |
| 2007 | 36 | 151 |
| 2008 | 41 | 160 |
| 2009 | 67 | 196 |
| 2010 | 93 | 272 |
| 2011 | 94 | 258 |
| 2012 | 136 | 298 |
| 2013 | 213 | 494 |
| 2014 | 296 | 589 |
| 2015 | 384 | 734 |
| 2016 | 458 | 722 |
| 2017 | 536 | 733 |
| 2018 | 480 | 672 |
| 2019 | 488 | 696 |
| 2020 | 464 | 699 |
| 2021 | 414 | 704 |
| 2022 | 385 | 770 |
| 2023 | 294 | 753 |
| 2024 | 358 | 918 |
| 2025 | 350 | 937 |
| 2026 | 275 | 817 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Amorphous nilotinib microparticles and uses thereof6 Oct 2026US 12,751,950 B2Flex Pharma, LLC
- CDK inhibitors6 Oct 2026US 12,751,951 B2Genentech, Inc.
- Combination therapy of PD-1 axis binding antagonists and LRRK2 inhitibors6 Oct 2026US 12,751,956 B2Hoffmann-La Roche Inc.
- Cannabidiol nanodrug formulations and methods for use of the same6 Oct 2026US 12,751,959 B2University of Miami
- Diaminopyrimidine carboxamide inhibitors of HPK16 Oct 2026US 12,753,163 B2Merck Sharp & Dohme Corp.
- Compositions, Kits, and Methods Comprising Bioidentical D BHB With Optional Vitamin B6 for Neurological Wellness, Mood Stability, and Medication Taper Support8 Oct 2026US 2026/0306430 A1Global Ketone Limited
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Combination therapy for pulmonary hypertension8 Oct 2026US 2026/0306461 A1Vivus, Inc.
- Inverse agonists of rar related orphan receptors (rors)8 Oct 2026US 2026/0306484 A111949098 CANADA INC. (NUREDCO) c/o Jean I. TCHERVENKOV
Most cited
By later US patents
- Methods for treating diabetic neuropathy258US 7,030,146 B2Kansas University Medical Center · 2006
- Intermediates useful for making 2,4-pyrimidinediamine compounds192US 7,060,827 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-disubstituted pyrimidines useful as kinase inhibitors178US 8,338,439 B2Celgene Avilomics Research, Inc. · 2012
- Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds176US 7,122,542 B2Rigel Pharmaceuticals, Inc. · 2006
- 2,4-pyrimidinediamine compounds and their uses176US 7,557,210 B2Rigel Pharmaceuticals, Inc. · 2009